Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 118905
Published online Jun 27, 2026. doi: 10.4254/wjh.118905
Published online Jun 27, 2026. doi: 10.4254/wjh.118905
Table 1 Baseline characteristics of the total cohort and subgroups with and without infection, n (%)/mean ± SD/median (interquartile range)
| Variable | Category | Total (n = 182) | Infection | |
| + (n = 39) | - (n = 143) | |||
| Age (years) | 67.84 ± 11.72 | 69.85 ± 10.68 | 67.29 ± 11.97 | |
| Sex | Male | 102 (56.0) | 26 (66.7) | 76 (53.1) |
| Female | 80 (44.0) | 13 (33.3) | 67 (46.9) | |
| ASA-PS | 0 | 2 (1.1) | 0 | 2 |
| 1 | 10 (5.5) | 1 | 9 | |
| 2 | 157 (86.3) | 35 | 122 | |
| 3 | 13 (7.1) | 3 | 10 | |
| Chronic kidney disease | Presence | 24 (13.2) | 3 (7.7) | 21 (14.7) |
| Diabetes mellitus | Presence | 48 (26.4) | 13 (33.3) | 35 (24.5 |
| Habitual smoking | Yes | 54 (29.7) | 14 (35.9 | 40 (28.0) |
| Habitual alcohol | Yes | 55 (30.2) | 10 (25.6) | 45 (31.5) |
| Malignant status | Malignant | 170 (93.4) | 38 (97.4) | 132 (92.3) |
| Metastatic liver tumors | 87 (47.8) | 21 (53.8) | 66 (46.2) | |
| HCC | 63 (34.6) | 13 (33.3) | 50 (35.0) | |
| CCC | 15 (8.2) | 3 (7.7) | 12 (8.4) | |
| Others | 5 (2.7) | 1 (2.6) | 4 (2.8) | |
| Benign | 12 (6.6) | 1 (2.6) | 11 (7.7) | |
| Child-Pugh | A | 178 (97.8) | 38 (97.4) | 140 (97.9) |
| B | 4 (2.2) | 1 (2.6) | 3 (2.1) | |
| ICG R15 | 10.0 (8.00-15.00) | 10.0 (8.0-15.0) | 10.0 (8.0-13.0) | |
| Body mass index (kg/m2) | 22.62 (20.37-24.86) | 23.44 (20.24-24.53) | 22.52 (20.48-25.02) | |
| Albumin (g/dL) | 4.05 (3.80-4.30) | 4.00 (3.70-4.30) | 4.10 (3.80-4.30) | |
| Albumin (g/dL) | < 3.5 | 18 (9.9) | 7 (17.9) | 11 (7.7) |
| ≥ 3.5 | 164 (90.1) | 32 (82.1) | 132 (92.3) | |
| PNI | 47.00 (44.12-50.50) | 48.0 (44.75-50.50) | 47.0 (44.00-50.50) | |
| PNI | < 45 | 53 (29.1) | 10 (25.6) | 43 (30.1) |
| ≥ 45 | 129 (70.9) | 29 (74.4) | 100 (69.9) | |
| Zn (μg/dL) | 72.00 (63.00-80.10) | 65.2 (57.05-76.25) | 72.00 (63.00-80.10) | |
| Zn (μg/dL) | < 80 | 132 (72.5) | 34 (87.2) | 98 (68.5) |
| ≥ 80 | 50 (27.5) | 5 (12.8) | 45 (31.5) | |
| CONUT score | 2.00 (1.00-2.00) | 1.00 (0.00-6.00) | 2.00 (0.00-6.00) | |
| CONUT score | 0-1 | 90 (49.5) | 22 (56.4) | 68 (47.6) |
| ≥ 2 | 92 (50.5) | 17 (43.6) | 75 (52.4) | |
| MIH approach | Laparoscopic | 87 (47.8) | 16 (41.0) | 71 (49.7) |
| Robotic | 95 (52.2) | 23 (59.0) | 72 (50.3) | |
| Operative procedure | Anatomical resection | 115 (63.2) | 27 (69.2) | 88 (61.5) |
| Partial resection | 67 (36.8) | 12 (30.8) | 55 (38.5) | |
| Iwate criteria | 6.00 (5.00-8.00) | 7.00 (2.00-11.00) | 6.00 (1.00-11.00) | |
| Operative time (hour) | 6.45 (4.50-7.97) | 6.85 (5.50-8.52) | 6.13 (4.28, 7.88) | |
| Estimated blood loss (mL) | 120.5 (61.3-284.5) | 178.0 (83.0-445.5) | 106.0 (55.00-261.5) | |
Table 2 Results of univariable and multivariable logistic regression analyses for postoperative infection
| Variable (reference) | Category or unit | Univariable logistic model | Multivariable logistic model | ||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Age (year) | 1 | 1.02 (0.99-1.06) | 0.228 | ||
| Sex (female) | Male | 1.76 (0.84-3.70) | 0.148 | ||
| ASA-PS (0-1) | 2-3 | 3.17 (0.396-25.3) | 0.277 | ||
| Chronic kidney disease | Presence | 0.48 (0.14-1.72) | 0.300 | ||
| Diabetes mellitus | Presence | 1.54 (0.72-3.32) | 0.306 | ||
| Habitual smoking | Yes | 1.44 (0.68-3.05) | 0.332 | ||
| Habitual alcohol consumption | Yes | 0.75 (0.34-1.67) | 0.558 | ||
| Malignant status (benign) | Malignant | 3.19 (0.40-25.50) | 0.467 | ||
| Child-Pugh (B) | A | 1.23 (0.12-12.1) | > 0.999 | ||
| ICG R15 (point) | 1 | 0.99 (0.94-1.04) | 0.574 | ||
| Body mass index (kg/m2) | 1 | 1.03 (0.95-1.12) | 0.572 | ||
| Albumin (g/dL) | 1 | 0.47 (0.18-1.21) | 0.115 | ||
| Albumin (≥ 3.5 g/dL) | < 3.5 | 2.62 (0.94-7.30) | 0.071 | 2.28 (0.79-6.57) | 0.126 |
| PNI (point) | 1 | 1.00 (0.92-1.07) | 0.898 | ||
| PNI (≥ 45 points) | < 45 | 0.80 (0.36-1.79) | 0.693 | ||
| Zn (μg/dL) | 1 | 0.96 (0.94-0.99) | 0.015 | 0.96 (0.94-0.99) | 0.009 |
| Zn (≥ 80 μg/dL) | < 80 | 0.32 (0.12-0.87) | 0.025 | 0.32 (0.11-0.90) | 0.032 |
| CONUT score (point) | 1 | 0.96 (0.74-1.25) | 0.455 | ||
| CONUT score (≥ 2 points) | 0-1 | 0.70 (0.34-1.43) | 0.369 | ||
| MIH approach (robot) | Lap | 1.42 (0.69-2.90) | 0.370 | ||
| Operative procedure (partial) | Anatomical | 0.71 (0.33-1.52) | 0.455 | ||
| Iwate criteria (point) | 1 | 1.05 (0.91-1.21) | 0.497 | ||
| Operative time (hour) | 1 | 1.17 (1.00-1.37) | 0.043 | 1.12 (0.93-1.34) | 0.228 |
| Estimated blood loss (mL) | 100 | 1.09 (1.00-1.19) | 0.039 | 1.08 (0.98-1.20) | 0.140 |
Table 3 Results of univariable and multivariable logistic regression analyses comparing Clavien–Dindo grade IIIa–negative and grade IIIa–positive groups
| Variable | Category or unit | Univariable logistic model | Multivariable logistic model | ||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Age (year) | 1 | 1.05 (0.97-1.14) | 0.190 | ||
| Sex (female) | Male | 0.98 (0.25-3.77) | 0.976 | ||
| ASA-PS (0-1) | 2-3 | 1.85 (0.21-16.13) | 0.581 | ||
| Chronic kidney disease | Presence | 0.82 (0.10-6.82) | 0.850 | ||
| Diabetes mellitus | Presence | 0.79 (0.16-3.93) | 0.772 | ||
| Habitual smoking | Yes | 1.97 (0.51-7.63) | 0.328 | ||
| Habitual alcohol consumption | Yes | 1.16 (0.28-4.83) | 0.835 | ||
| Malignant status (benign) | Malignant | 1.48 (0.17-194.84)1 | 0.7801 | ||
| Child-Pugh (B) | A | 0.141(0.013-1.52) | 0.106 | ||
| ICG R15 (point) | 1 | 0.96 (0.84-1.10) | 0.559 | ||
| Body mass index (kg/m2) | 1 | 0.77 (0.61-0.97) | 0.029 | 0.79 (0.61-1.02) | 0.066 |
| Albumin (g/dL) | 1 | 0.15 (0.02-0.91) | 0.039 | 0.54 (0.07-4.19) | 0.558 |
| Albumin (≥ 3.5 g/dL) | < 3.5 | 3.15 (0.58-17.00) | 0.183 | ||
| PNI (point) | 1 | 0.98 (0.85-1.13) | 0.752 | ||
| PNI (≥ 45 points) | < 45 | 0.68 (0.14-3.40) | 0.642 | ||
| Zn (μg/dL) | 1 | 0.93 (0.88-0.98) | 0.007 | 0.94 (0.88-1.00) | 0.046 |
| Zn (≥ 80 μg/dL) | < 80 | 7.77 (0.95-1008.52)1 | 0.0571 | ||
| CONUT score (point) | 1 | 0.62 (0.33-1.17) | 0.139 | ||
| CONUT score (≥ 2 points) | 0-1 | 0.26 (0.05-1.30) | 0.102 | ||
| MIH approach (robot) | Lap | 3.38 (0.68-16.70) | 0.136 | ||
| Operative procedure (partial) | Anatomical | 0.48 (0.10-2.35) | 0.362 | ||
| Iwate criteria (point) | 1 | 1.33 (0.98-1.81) | 0.070 | ||
| Operative time (minute) | 1 | 1.55 (1.13-2.13) | 0.006 | 1.58 (1.09-2.30) | 0.016 |
| Estimated blood loss (mL) | 100 | 1.06 (0.92-1.21) | 0.429 | ||
Table 4 Preoperative serum zinc level-specific infection rates, n (%)
| Serum zinc level (μg/dL) | Number of patients | Number of infected patients |
| < 60 | 32 | 11 (34.4) |
| 60 to < 70 | 46 | 11 (23.9) |
| 70 to < 80 | 54 | 12 (22.2) |
| ≥ 80 | 50 | 5 (10.0) |
Table 5 Comparison of baseline characteristics according to preoperative serum zinc level, n (%)/median (interquartile range)
| Variable | Category | Preoperative serum zinc level | P value | |
| < 80 μg/dL (n = 132) | ≥ 80 μg/dL (n = 50) | |||
| Age (years) | 69.61 (10.96) | 63.16 (12.46) | 0.001 | |
| Sex | Male | 73 (55.3) | 29 (58.0) | 0.867 |
| Female | 59 (44.7) | 21 (42.0) | ||
| ASA-PS | 0 | 1 (0.8) | 1 (2.0) | 0.212 |
| 1 | 6 (4.5) | 4 (8.0) | ||
| 2 | 113 (85.6) | 44 (88.0) | ||
| 3 | 12 (9.1) | 1 (2.0) | ||
| Chronic kidney disease | Presence | 19 (14.4) | 5 (10.0) | 0.624 |
| Diabetes mellitus | Presence | 35 (26.5) | 13 (26.0) | > 0.999 |
| Habitual smoking | Yes | 40 (30.3) | 14 (28.0) | 0.857 |
| Habitual alcohol | Yes | 40 (30.3) | 15 (30.0) | > 0.999 |
| Malignant status | Malignant | 128(96.9) | 42 (84.0) | 0.004 |
| Benign | 4 (3.1) | 8 (16.0) | ||
| Child-Pugh | A | 129 (97.7) | 49 (98.0) | > 0.999 |
| B | 3 (2.3) | 1 (2.0) | ||
| ICG R15 | 11.0 (8.0-15.0) | 10.0 (7.3-12.8) | 0.094 | |
| Body mass index (kg/m2) | 23.1 (4.2) | 23.1 (3.9) | 0.964 | |
| Albumin (g/dL) | 3.99 (0.37) | 4.20 (0.36) | 0.001 | |
| Albumin (g/dL) | < 3.5 | 17 (12.9) | 1 (2.0) | 0.027 |
| ≥ 3.5 | 115 (87.1) | 49 (98.0) | ||
| PNI | 46.80 (4.55) | 48.87 (4.63) | 0.007 | |
| PNI | < 45 | 42 (31.8) | 11 (22.0) | 0.207 |
| ≥ 45 | 90 (68.2) | 39 (78.0) | ||
| CONUT score | 2.0 (0.0-6.0) | 1.0 (0.0-5.0) | 0.428 | |
| CONUT score | 0-1 | 63 (47.7) | 27 (54.0) | 0.508 |
| ≥ 2 | 69 (52.3) | 23 (46.0) | ||
| MIH approach | Lap | 62 (47.0) | 25 (50.0) | 0.742 |
| Robot | 70 (53.0) | 25 (50.0) | ||
| Operative procedure | Anatomical | 83 (62.9) | 32 (64.0) | 1.000 |
| Partial | 49 (37.1) | 18 (36.0) | ||
| Iwate criteria | 6.0 (1.0-11.0) | 6.5 (2.0-11.0) | 0.683 | |
| Operative time (minute) | 6.48 (4.55-7.90) | 6.16 (4.17-8.36) | 0.928 | |
| Estimated blood loss (mL) | 128 (2.0-2520) | 94 (3.0-1544) | 0.304 | |
- Citation: Murase H, Matsuo Y, Nakatani E, Denda Y, Nonoyama K, Kato T, Saito K, Sato T, Morimoto M, Yamakawa Y, Sagawa H, Takiguchi S. Association between preoperative serum zinc levels and postoperative infectious complications after minimally invasive hepatectomy: A retrospective cohort study. World J Hepatol 2026; 18(6): 118905
- URL: https://www.wjgnet.com/1948-5182/full/v18/i6/118905.htm
- DOI: https://dx.doi.org/10.4254/wjh.118905